Avalia Immunotherapies is a biotechnology company based in Astoria, NY, specializing in immune modulators targeting the liver to enhance innate and adaptive immunity.
The company focuses on developing innovative therapies for chronic hepatitis B, malaria, influenza, virus-associated cancers, and solid tumors, with a robust pipeline of potential treatments.
Generated from the website